South Korean digital radiography (DR) manufacturer DRGEM issued a statement saying it disagrees with the jury's verdict in its patent infringement lawsuit with Spanish x-ray developer Sociedad Española de Electromedicina y Calidad (Sedecal) and is working to have the decision overturned.
The jury's decision will have no effect on DRGEM's ongoing U.S. business operations, the company said. Six months before the trial began -- in July of 2015 -- DRGEM stopped importing the allegedly infringing high-voltage transformer at issue. All DRGEM x-ray generator products now sold in the U.S. include a new transformer design, which has never been accused of infringing any patent, including the Sedecal patent, according to the firm.
"DRGEM is ready and able to continue providing superior quality x-ray equipment which incorporates its innovative and new transformer design to customers in the U.S.," DRGEM added.
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
